Sustainability | April 22, 2026
Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
Manoj has over two decades of experience in healthcare operations and biomedical engineering
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
Subscribe To Our Newsletter & Stay Updated
